课题基金 / 基金详情

Control of c-Myc Function by the Tumor Suppressor p19ARF

Control of c-Myc Function by the Tumor Suppressor p19ARF
肿瘤抑制因子 p19ARF 对 c-Myc 功能的控制
批准号:
7224928
负责人:
STEPHEN R. HANN
金额:
$26.42万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2004
资助国家:
美国
项目状态:
已结题
起止时间:
2004-07-06 至 2009-04-30

项目摘要

项目成果

STEPHEN R. HANN的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): We have shown that p19ARF protein binds and colocalizes with c-Myc protein, both exogenously and endogenously. ARF binding to c-Myc inhibits c-Myc transactivation of target genes and c- Myc-induced hyperproliferation and transformation. Furthermore, ARF does not inhibit repression of c-Myc target genes and actually appears necessary for Inr-mediated repression and enhances c- Myc-induced apoptosis. ARF also inhibits the proteolysis of c-Myc. The further characterization and functional relevance of this interaction is the focus of this proposal. Our hypothesis is that direct ARF interaction with c-Myc selectively regulates the activity of c-Myc protein. Therefore, loss of this important checkpoint control would contribute to deregulation of c-Myc function leading to hyperproliferation, transformation and inhibition of apoptosis. To test this hypothesis the following specific aims will be performed. Specific Aim I will be to characterize the biochemical interaction between c-Myc and ARF. Specific Aim 2 will be to determine the molecular mechanism that mediates the regulation of c-Myc activity by ARF. Specific Aim 3 will be to determine the biological role of the interaction of ARF with c-Myc. Our novel findings and the results of experiments proposed in these specific aims will have major implications for the function of c-Myc, ARF and p53. Our findings have already impacted the controversial model on the molecular function of c-Myc and will likely continue to impact the course of c-Myc studies on how c-Myc functions at the molecular level to elicit such powerful control over cellular proliferation, tumorigenesis and apoptosis. Finally, the inhibition of c-Myc-induced transformation and enhancement of c-Myc-induced apoptosis by ARF has direct therapeutic significance for cancer treatment.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Integrated Biological Systems Training in Oncology
  • 批准号:
    8551189
  • 项目类别:
  • 资助金额:
    $39.02万
  • 财政年份:
    2008
  • 负责人:
    STEPHEN R. HANN
  • 依托单位:
Integrated Biological Systems Training in Oncology
  • 批准号:
    7858526
  • 项目类别:
  • 资助金额:
    $42.06万
  • 财政年份:
    2008
  • 负责人:
    STEPHEN R. HANN
  • 依托单位:
Integrated Biological Systems Training in Oncology
  • 批准号:
    9404542
  • 项目类别:
  • 资助金额:
    $1.28万
  • 财政年份:
    2008
  • 负责人:
    STEPHEN R. HANN
  • 依托单位:
Integrated Biological Systems Training in Oncology
  • 批准号:
    7626729
  • 项目类别:
  • 资助金额:
    $41.78万
  • 财政年份:
    2008
  • 负责人:
    STEPHEN R. HANN
  • 依托单位:
国内基金
海外基金
Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
  • 批准号:
    LBY21H010001
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2020
  • 负责人:
    郑绪阳
  • 依托单位:
基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
  • 批准号:
    81703335
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    20.0万元
  • 批准年份:
    2017
  • 负责人:
    卫高菲
  • 依托单位:
双肝移植后Apoptosis和pyroptosis在移植物萎缩差异中的作用和供受者免疫微环境变化研究
  • 批准号:
    81670594
  • 项目类别:
    面上项目
  • 资助金额:
    58.0万元
  • 批准年份:
    2016
  • 负责人:
    陈昊
  • 依托单位:
Serp-2 调控apoptosis和pyroptosis 对肝脏缺血再灌注损伤的保护作用研究
  • 批准号:
    81470791
  • 项目类别:
    面上项目
  • 资助金额:
    73.0万元
  • 批准年份:
    2014
  • 负责人:
    董家鸿
  • 依托单位: